Education
About Us
Working with TipRanks
Follow Us
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
See the Price Targets and Ratings of:
CTXR Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
D. Boral Capital
$9
Buy
480.65%
Upside
Upgraded
12/30/24
D. Boral Capital upgrades Citius Pharmaceuticals (CTXR) to BuyD. Boral Capital analyst Jason Kolbert upgraded Citius Pharmaceuticals (NASDAQ: CTXR) from Hold to Buy with a price target of $9.00.
Maxim Group
―
Buy
―
Reiterated
11/26/24
Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments
H.C. Wainwright
$100
Buy
6351.61%
Upside
Reiterated
11/12/24
Buy Rating for Citius Pharmaceuticals: Promising Clinical Results and Strong Financial Outlook
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
D. Boral Capital
$9
Buy
480.65%
Upside
Upgraded
12/30/24
D. Boral Capital upgrades Citius Pharmaceuticals (CTXR) to BuyD. Boral Capital analyst Jason Kolbert upgraded Citius Pharmaceuticals (NASDAQ: CTXR) from Hold to Buy with a price target of $9.00.
Maxim Group
―
Buy
―
Reiterated
11/26/24
Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments
H.C. Wainwright
$100
Buy
6351.61%
Upside
Reiterated
11/12/24
Buy Rating for Citius Pharmaceuticals: Promising Clinical Results and Strong Financial Outlook
CTXR Analyst Recommendation Trends
Rating
May 24
Jul 24
Aug 24
Nov 24
Dec 24
Strong Buy
7
5
6
5
5
Buy
0
0
0
1
1
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
5
6
7
7
Each month's total comprises the sum of three months' worth of ratings.
CTXR Stock Forecast FAQ
What is CTXR’s average 12-month price target, according to analysts?
Based on analyst ratings, Citius Pharmaceuticals’s 12-month average price target is $9.00.
What is CTXR’s upside potential, based on the analysts’ average price target?
Citius Pharmaceuticals has 480.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CTXR a Buy, Sell or Hold?
Citius Pharmaceuticals has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Citius Pharmaceuticals’s price target?
The average price target for Citius Pharmaceuticals is $9.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $9.00. The average price target represents 480.65% Increase from the current price of $1.55.
The highest analyst price target is $9.00 ,the lowest forecast is $9.00. The average price target represents 480.65% Increase from the current price of $1.55.
What do analysts say about Citius Pharmaceuticals?
Citius Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of CTXR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.